Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543998 | NSE Symbol : VALIANTLAB | ISIN : INE0JWS01017 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
05-Jul-2025	09-Jul-2025	Raising funds through Debt Instr.	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2025 inter alia to consider and approve proposal for raising of funds by way of issue of securities through further public offer rights issue American Depository Receipts/ Global Depository Receipts/ Foreign Currency Convertible Bonds qualified institutions placement debt issue preferential issue or any other method as may be decided and considered appropriate subject to such regulatory/statutory approvals as may be required and matters related and incidental thereto. Considered and approved 1) Fund raising via Rights Issue and 2) Appointment of the Company Secretary and Compliance Officer The board on July 09, 2025, has considered and approved raising of via Rights Issue. (As Per BSE Announcement Dated on 09.07.2025)
14-May-2025	20-May-2025	Accounts	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Board Meeting Intimation for Considering and Approving Audited Standalone And Consolidated Financial Results for the Quarter and Year Ended March 31 2025. Financial Results for the quarter and year ended March 31, 2025 (As Per BSE Announcement Dated on: 20/05/2025)
31-Jan-2025	07-Feb-2025	Quarterly Results	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter ended December 31 2024. Outcome of the Board Meeting dated February 07, 2025. Financial Results for the quarter ended December 31, 2024. (As per BSE Announcement Dated on 07/02/2025)
07-Nov-2024	12-Nov-2024	Accounts	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2024 and any other business matters if required with the permission of the Chairman. Appointment of Mr. Ashok Chheda as a Non- Executive Independent Director of the Company. (As Per BSE Announcement Dated on: 12/11/2024)
06-Aug-2024	12-Aug-2024	Quarterly Results	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for the quarter ended June 30 2024 Outcome of the Board Meeting (As Per Bse Announcement Dated on 12.08.2024)
07-May-2024	14-May-2024	Accounts	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve Standalone and Consolidated audited Financial Results for the quarter and year ended March 31 2024 and other business matters if required with the permission of the Chairman. Outcome of the Board Meeting Appointment of Mr. Mulesh Manilal Savla as Non- Executive Independent Director of the Company. (As Per BSE Announcement dated on 14.05.2024)
01-Feb-2024	09-Feb-2024	Quarterly Results	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Audited Financial Results for the Quarter ended December 31 2023. Outcome of the Board Meeting (As Per BSE Announcement dated on 09.02.2024)
30-Oct-2023	06-Nov-2023	Quarterly Results	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Audited Financial Results for the Quarter and Half Year ended September 30 2023. Outcome of Board Meeting Audited Financial Results for Quarter and Half year ended September 30, 2023. (As Per BSE Announcement dated on 06.11.2023)

LOGIN HERE

Valiant Laboratories Ltd

Board Meeting